About
Alentis Therapeutics is a clinical-stage biotech company developing antibody-drug conjugates and monoclonal antibodies targeting Claudin-1 to treat cancer and reverse fibrosis.
Explore Alentis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.